Coronavirus and Ophthalmology Best Practices with Rishi Singh, MD

Article

Rishi Singh, MD, of Cole Eye Institute, discusses steps to take to help prevent the spread of coronavirus in ophthalmology practices.

While most elective procedures have been canceled and many practices have temporarily closed as a result of the coronavirus disease 2019 (COVID-19), many ophthalmology practices find themselves in a unique and difficult situation.

With so many ophthalmic procedures directly tied to a patient’s quality of life, some patients may be reluctant to cancel and delay injections or other procedures that may require a specific treatment interval.

Due to the nature of treating ophthalmic conditions and how they require close contact with patients, our sister publication Ophthalmology Times reached out to Rishi Singh, MD, of the Cole Eye Institute at the Cleveland Clinic, for more perspective on steps to take to protect ophthalmologists and their patients.

Related Videos
Hong-Uyen Hua, MD; Sruthi Arepalli, MD; and Peter Kaiser, MD
Kelly Nichols, OD; Laura Periman, MD; and Mile Brujic, OD
Cindy X. Cai, MD: Impact of Race, Neighborhood on Diabetic Retinopathy Care | Image Credit: Johns Hopkins University
Dimitra Skondra, MD, PhD: Protective Effect of Metformin in Geographic Atrophy| Image Credit: University of Chicago
Deepak Sambhara, MD | Image Credit: American Society of Retina Specialists
Sean Adrean, MD: Impact of Baseline VA on Aflibercept 8 mg Outcomes in DME | Image Credit: Linkedin
Mark Barakat, MD: Stable IOP Outcomes After Aflibercept 8 mg in DME | Image Credit: Retina Macula Institute of Arizona
Getting Black Men Involved in Their Health Care, Clinical Research
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
© 2024 MJH Life Sciences

All rights reserved.